Fenfluramine, once a popular weight loss drug, is now linked to pulmonary arterial hypertension (PAH), prompting its market withdrawal. However, its re-emergence in treating drug-resistant epilepsy underscores the importance of understanding its effects. This article delves into genetic predispositions, latency periods, and survival rates, offering insights into managing fenfluramine-associated PAH. Understanding Fenfluramine and Its Link […]

In Massachusetts, a wealth of clinical trials offers hope for those affected by osteoarthritis, a condition that impairs mobility and causes significant pain. These studies, particularly concentrated in Boston, explore diverse treatment strategies, from lifestyle changes to advanced medical interventions. Participants not only gain access to innovative therapies but also contribute to crucial scientific advancements […]

Fatty liver disease, particularly non-alcoholic fatty liver disease (NAFLD), is a prevalent condition marked by excessive fat in the liver, affecting up to 40% of Americans. While often asymptomatic, it is linked to obesity and metabolic issues. Explore the diagnosis, risk factors, and effective lifestyle changes that can significantly improve liver health and overall well-being. […]

The intersection of HIV drug treatments and non-alcoholic steatohepatitis (NASH) presents a significant challenge for individuals living with HIV. As antiretroviral therapy (ART) can exacerbate liver conditions, understanding its impact is crucial for effective management. This article delves into the complexities of ART’s role in liver disease, current and investigational treatments, and essential lifestyle modifications. […]

Type 2 diabetes, a prevalent chronic condition, demands effective management to prevent serious health complications. By embracing lifestyle changes, dietary adjustments, and regular physical activity, individuals can significantly improve their health outcomes. This article delves into practical strategies and essential support systems that empower individuals to manage Type 2 diabetes effectively and lead healthier lives. […]

Fenfluramine, once a popular weight loss drug, has been linked to pulmonary arterial hypertension (PAH), a serious condition affecting lung arteries. Genetic predispositions, clinical characteristics, and its re-emergence in epilepsy treatment highlight the complexities of its use. Understanding these aspects is vital for managing risks and ensuring safe application in vulnerable populations. Understanding Fenfluramine and […]